期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
dbSCI:A manually curated database of SARS-CoV-2 inhibitors for COVID-19
1
作者 QIANG WANG GUO ZHAO +6 位作者 longxiang xie XUAN LI XIXI YU QIONGSHAN LI BAOPING ZHENG ZULIPINUER WUSIMAN XIANGQIAN GUO 《BIOCELL》 SCIE 2023年第2期367-371,共5页
Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is the pathogen of the ongoing coronavirus disease 2019(COVID-19)global pandemic.Here,by centralizing published cell-based experiments,clinical trials,and vir... Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is the pathogen of the ongoing coronavirus disease 2019(COVID-19)global pandemic.Here,by centralizing published cell-based experiments,clinical trials,and virtual drug screening data from the NCBI PubMed database,we developed a database of SARS-CoV-2 inhibitors for COVID-19,dbSCI,which includes 234 SARS-CoV-2 inhibitors collected from publications based on cell-based experiments,81 drugs of COVID-19 in clinical trials and 1305 potential SARS-CoV-2 inhibitors from bioinformatics analyses.dbSCI provides four major functions:(1)search the drug target or its inhibitor for SARS-CoV-2,(2)browse target/inhibitor information collected from cell experiments,clinical trials,and virtual drug screenings,(3)download,and(4)submit data.Each entry in dbSCI contains 18 types of information,including inhibitor/drug name,targeting protein,mechanism of inhibition,experimental technique,experimental sample type,and reference information.In summary,dbSCI provides a relatively comprehensive,credible repository for inhibitors/drugs against SARS-CoV-2 and their potential targeting mechanisms and it will be valuable for further studies to control COVID-19. 展开更多
关键词 SARS-CoV-2 COVID-19 INHIBITORS DRUGS DATABASE
下载PDF
Protein post-translational modification by lysine succinylation:Biochemistry,biological implications,and therapeutic opportunities 被引量:1
2
作者 Guo Zhao Junfeng Zhen +4 位作者 Xinyuan Liu Jinshuai Guo Duanduan Li Jianping xie longxiang xie 《Genes & Diseases》 SCIE CSCD 2023年第4期1242-1262,共21页
Lysine succinylation(Ksuc)is a novel protein post-translational modification(PTM)wherein a succinyl group modifies a lysine residue.Ksuc leads to significant chemical and struc-tural changes to the modified protein.Re... Lysine succinylation(Ksuc)is a novel protein post-translational modification(PTM)wherein a succinyl group modifies a lysine residue.Ksuc leads to significant chemical and struc-tural changes to the modified protein.Recent studies have shown that Ksuc might play an important role in organism physiology and some pathophysiological processes,such as tumor-igenesis and metabolic diseases.To provide an understanding of the molecular mechanism and functions of Ksuc in different organisms,we reviewed the current literature about Ksuc,mainly summarizing the research advances in eukaryotes and prokaryotes based on both traditional study methods and site prediction tools.We also discussed inhibitors or activators associated with Ksuc that may contribute to proteomic studies and could be useful in future clinical prac-tice.A deeper understanding of Ksuc may shed new light on life science at the protein level and could lead to novel therapeutic strategies for various diseases. 展开更多
关键词 Disease EUKARYOTES Lysine succinylation Physiology PROKARYOTES Protein post-translational modification
原文传递
OStme: Online consensus survival analysis web server for tumor microenvironment components of pan-cancers
3
作者 longxiang xie Qiang Wang +6 位作者 Xiaoyu Ma Guo Zhao Zhongyi Yan Huimin Li Wan Zhu Zhanjie Zuo Xiangqian Guo 《Genes & Diseases》 SCIE CSCD 2023年第6期2256-2259,共4页
Tumor microenvironment(TME)is the environment around the tumor cells,consisting of extracellular matrix,nonmalignant stromal cells,and various types of immune cells(like macrophages,B and T lymphocytes).1 TME has been... Tumor microenvironment(TME)is the environment around the tumor cells,consisting of extracellular matrix,nonmalignant stromal cells,and various types of immune cells(like macrophages,B and T lymphocytes).1 TME has been recurrently reported to play important roles in the progression of cancers.1 The mechanism study of TME may offer opportunities for targeted/immune therapies.However,how TME components impact the prognosis of cancer patients remains to be determined. 展开更多
关键词 CANCERS MICROENVIRONMENT PROGNOSIS
原文传递
新型抗结核药物研发:微生物非常规培养与沉默基因激活策略 被引量:3
4
作者 滕铁山 谢龙祥 谢建平 《生物工程学报》 CAS CSCD 北大核心 2018年第8期1306-1315,共10页
由结核分枝杆菌感染引起的结核病是人类重要传染病之一。临床上结核菌耐药性日趋严重,不断出现的耐多药及广泛耐药结核病患者,使现有的一线至五线药物不能满足结核病防控需求。微生物来源的天然产物是药物先导化合物的重要来源。环境中... 由结核分枝杆菌感染引起的结核病是人类重要传染病之一。临床上结核菌耐药性日趋严重,不断出现的耐多药及广泛耐药结核病患者,使现有的一线至五线药物不能满足结核病防控需求。微生物来源的天然产物是药物先导化合物的重要来源。环境中存在大量常规培养条件下未培养微生物,同时微生物基因组中也存在大量未被表达的"沉默代谢途径"。运用各种方法对未培养微生物进行再培养,同时激活微生物的沉默代谢途径,进而获得潜在的新型抗生素药物已成为目前研究热点。文中系统阐述了近年来获取天然化合物所采用的微生物非常规培养技术及沉默代谢途径激活策略,同时总结了利用这两种方法获得的新型抗结核天然产物,并展望了这些方法在抗结核药物进一步研发中的应用前景。 展开更多
关键词 结核分枝杆菌 未培养微生物 沉默基因 单株菌-多次级代谢产物(OSMAC)
原文传递
翻译后修饰与结核分枝杆菌耐药调控网络 被引量:1
5
作者 谢龙祥 党艺方 谢建平 《生物工程学报》 CAS CSCD 北大核心 2018年第8期1279-1287,共9页
目前对于结核分枝杆菌(Mycobacterium tuberculosis,Mtb)耐药产生机制研究得较多,但对其调控机制的研究较少。翻译后修饰(Post-translational modifications,PTMs)在结核菌多种生理途径(如代谢、应激反应等)中发挥重要调控作用,而它们... 目前对于结核分枝杆菌(Mycobacterium tuberculosis,Mtb)耐药产生机制研究得较多,但对其调控机制的研究较少。翻译后修饰(Post-translational modifications,PTMs)在结核菌多种生理途径(如代谢、应激反应等)中发挥重要调控作用,而它们和结核菌耐药之间的关系逐渐引起了研究者的关注。文中介绍了结核菌抗生素耐受机制以及存在的一些PTMs,重点讨论了PTMs在调控结核杆菌耐药机制中的潜在作用,以期为新型抗结核药物研发提供新的切入点。 展开更多
关键词 翻译后修饰 结核分枝杆菌 抗生素 耐药
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部